Finance

Lists
Why is SNW down 3,44%?
Dive Deeper
SNW:ETR
Sanofi SA
€70,70
-3,44%
(-2,52) 1D
2 ຕ.ລ., 17 ໂມງ 35 ນາທີ 42 ວິນາທີ GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SNW...
Open
€70,79
High
€71,24
Low
€69,77
Mkt. cap
85,38 ຕື້
Avg. vol.
11,43 ພັນ
Volume
44,02 ພັນ
P/E ratio
21,68
52-wk high
€90,75
52-wk low
€69,77
EPS
€3,26
Shares outstanding
1,25 ຕື້
No. of employees
75 ພັນ
Open
€70,79
High
€71,24
Low
€69,77
Mkt. cap
85,38 ຕື້
Avg. vol.
11,43 ພັນ
Volume
44,02 ພັນ
P/E ratio
21,68
52-wk high
€90,75
52-wk low
€69,77
EPS
€3,26
Shares outstanding
1,25 ຕື້
No. of employees
75 ພັນ
News stories
From web sources and news partners
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000. Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOPaul Hudson | Belén Garijo
Employees74,8 ພັນ
Founded1973
Headquartersປາລີ, Île-de-France, ຝຣັ່ງ
SectorPharmaceutical industry
Websitesanofi.com
Last report
30 ກ.ລ. 2026
Fiscal period
Q2 2026
EPS / Est. (EUR)
- / €1,90
Revenue / Est. (EUR)
12,30 ຕື້ / 10,89 ຕື້
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
13,17 ຕື້
12,20 ຕື້
11,24 ຕື້
12,30 ຕື້
Cost of goods sold
3,41 ຕື້
3,63 ຕື້
3,06 ຕື້
2,89 ຕື້
Cost of revenue
3,41 ຕື້
3,63 ຕື້
3,06 ຕື້
2,89 ຕື້
Research and development expenses
1,83 ຕື້
2,29 ຕື້
1,75 ຕື້
2,23 ຕື້
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,29 ຕື້
2,82 ຕື້
2,33 ຕື້
2,49 ຕື້
Operating expense
5,97 ຕື້
6,84 ຕື້
5,94 ຕື້
6,82 ຕື້
Total operating expenses
9,39 ຕື້
10,46 ຕື້
9,00 ຕື້
9,71 ຕື້
Operating income
3,78 ຕື້
1,74 ຕື້
2,25 ຕື້
2,59 ຕື້
Other non operating income
-
122,00 ລ້ານ
-40,00 ລ້ານ
-91,00 ລ້ານ
EBT including unusual items
3,51 ຕື້
-1,16 ຕື້
2,01 ຕື້
828,00 ລ້ານ
EBT excluding unusual items
3,67 ຕື້
1,70 ຕື້
2,14 ຕື້
2,40 ຕື້
Income tax expense
680,00 ລ້ານ
-348,00 ລ້ານ
420,00 ລ້ານ
451,00 ລ້ານ
Effective tax rate
19,38%
30,13%
20,85%
54,47%
Other operating expenses
1,39 ຕື້
1,19 ຕື້
1,33 ຕື້
1,55 ຕື້
Net income
2,80 ຕື້
-801,00 ລ້ານ
1,61 ຕື້
343,00 ລ້ານ
Net profit margin
21,28%
-6,56%
14,35%
2,79%
Earnings per share
-
1,53
1,88
-
Interest and investment income
114,00 ລ້ານ
79,00 ລ້ານ
60,00 ລ້ານ
64,00 ລ້ານ
Interest expense
-227,00 ລ້ານ
-
-138,00 ລ້ານ
-153,00 ລ້ານ
Net interest expenses
-113,00 ລ້ານ
79,00 ລ້ານ
-78,00 ລ້ານ
-89,00 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
4,20 ຕື້
3,49 ຕື້
2,78 ຕື້
3,83 ຕື້
Gain or loss from assets sale
266,00 ລ້ານ
-79,00 ລ້ານ
-
-9,00 ລ້ານ
AI content may include mistakes. Learn more
ແອັບຂອງ Google